Clinical trials
Not yet recruiting Carcinoma, Ovarian Epithelial trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 1 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 12 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shanghai Gynecologic Oncology Group | 4 |
| Anhui Provincial Hospital | 2 |
| Asan Medical Center | 1 |
| Başakşehir Çam & Sakura City Hospital | 1 |
| BeOne Medicines | 1 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 1 |
| Genmab | 1 |
| Massachusetts General Hospital | 1 |
| Medigene AG | 1 |
| Peking University Cancer Hospital & Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Ovarian Epithelial | 20 |
| Ovarian Neoplasms | 11 |
| Fallopian Tube Neoplasms | 9 |
| Liposarcoma, Myxoid | 1 |
| Neoplasm, Residual | 1 |
| Sarcoma | 1 |
| Sarcoma, Synovial | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.